Search All News
Cardiovascular disease is the No. 1 cause of maternal mortality in the United States, but a new study suggests specialized cardio-obstetrics teams may improve outcomes.
Columbia researchers have uncovered an array of new genes that cause stillbirth, significantly increasing the understanding of the genetic foundations of a common, but little studied, condition.
- December 19, 2012
A team of scientists from The New York Stem Cell Foundation Laboratory and CUMC has developed a technique that may prevent the inheritance of mitochondrial diseases in children.
Source:The Wall Street JournalDecember 13, 2012
CUMC's Ob/Gyn Chair Mary D'Alton: Hospitals should follow standard prevention measures, e.g., giving a blood thinner to patients after a C-section.
- December 10, 2012
Women with breast cancer for whom chemotherapy is most critical are most likely to begin treatment.
Source:Time MagazineDecember 7, 2012
Chromosomal microarray, which compares a fetus' DNA to that of a normal genome, should be offered to all expectant mothers, say CUMC researchers.
- December 7, 2012
A new genetic test may help detect abnormalities in 40% more cases of stillbirth - co-authored by Columbia's Dr. Brynn Levy.
- December 5, 2012
A new genetic test, microarray, found significantly more clinically relevant information than the standard method - results in NEJM.
Source:New York Daily NewsOctober 5, 2012
Dr. Alfred Neugut plans to analyze how costs & other factors affect breast cancer treatment adherence--study sponsored by American Cancer Society
Source:The New York TimesAugust 28, 2012
Dr. Ethel Siris notes the severity of fractures late in life. “When you break a hip at 80, it can be a life-ending experience.”
Source:The New York TimesAugust 9, 2012
Encouraging clinical trial results for microarray, a new prenatal test that can detect more genetic problems than ever before.
- June 26, 2012
Prenatal exposure to ubiquitous household chemical in vinyl flooring can increase a child’s risk for developing eczema.